Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product

EMBO Journal

Volumn 16, Issue 17, 1997, Pages 5310-5321

  Vallone, Daniela ^a   Battista, Sabrina ^b   Pierantoni, Giovanna Maria ^a   Fedele, Monica ^b   Casalino, Laura ^a   Santoro, Massimo ^c   Viglietto, Giuseppe ^b   Fusco, Alfredo ^d   Verde, Pasquale ^a  

^a INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

Author keywords

AP 1; fra 1; HMGI; Neoplastic transformation; Thyroid

Indexed keywords

COMPLEMENTARY RNA; GENE PRODUCT; HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP PROTEIN; MESSENGER RNA; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL TRANSFORMATION; CHROMATIN; CONTROLLED STUDY; GENE INDUCTION; GENETIC TRANSFECTION; IMMUNOBLOTTING; NONHUMAN; ONCOGENE; ONCOGENE C JUN; ONCOGENE FRO 1; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RAT; THYROID CELL; TRANSCRIPTION INITIATION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HIGH MOBILITY GROUP PROTEINS; HMGA2 PROTEIN; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RNA, ANTISENSE; RNA, MESSENGER; RNA, NEOPLASM; THYROID GLAND; THYROID NEOPLASMS; TRANSCRIPTION FACTOR AP-1;

ANIMALIA;

EID: 0030863948     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/16.17.5310     Document Type: Article

References (57)

1. Abate, C. and Curran, T. (1990) Encounters with Fos and Jun on the road to AP-1. Semin. Cancer Biol., 1, 19-26.
2. Angel, P. and Karin, M. (1991) The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta, 1072, 129-157.
3. Angel, P., Imagawa, M., Chiu, R., Stein, B., Imbra, R.J., Rahmsdorf, H.J., Jonat, C., Herrlich, P. and Karin, M. (1987) Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans acting factor. Cell, 49, 729-739.
4. Arias, J., Alberts, A.S., Brindle, P., Claret, F.X., Smeal, T., Karin, M., Feramisco, J. and Montminy, M. (1994) Activation of cAMP and mitogen responsive genes relies on a common nuclear factor [see comments]. Nature, 370, 226-229.
5. Ashar, H.R., Fejzo, M.S., Tkachenko, A., Zhou, X., Fletcher, J.A., Weremowicz, S., Morton, C.C. and Chada, K. (1995) Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell, 82, 57-65.
6. Bannister, A.J., Oehler, T., Wilhelm, D., Angel, P. and Kouzarides, T. (1995) Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro. Oncogene, 11, 2509-2514.
7. Bergers, G., Graninger, P., Braselmann, S., Wrighton, C. and Busslinger, M. (1995) Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron. Mol. Cell. Biol., 15, 3748-3758.
8. Berlingieri, M.T., Portella, G., Grieco, M., Santoro, M. and Fusco, A. (1988) Cooperation between the polyomavirus middle-T-antigen gene and the human c-myc oncogene in a rat thyroid epithelial differentiated cell line: model of in vitro progression. Mol. Cell. Biol., 8, 2261-2266.
9. Berlingieri, M.T., Santoro, M., Battaglia, C., Grieco, M. and Fusco, A. (1993) The adenovirus E1A gene blocks the differentiation of a thyroid epithelial cell line, however the neoplastic phenotype is achieved only after cooperation with other oncogenes. Oncogene, 8, 249-255.
10. Berlingieri, M.T., Manfioletti, G., Santoro, M., Bandiera, A., Visconti, R., Giancotti, V. and Fusco, A. (1995) Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol. Cell. Biol., 15, 1545-1553.
11. Boyle, W.J., Smeal, T., Defize, L.H., Angel, P., Woodgett, J.R., Karin, M. and Hunter, T. (1991) Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell, 64, 573-584.
12. Breathnach, R., Matrisian, L.M., Gesnel, M.C. Staub, A. and Leroy, P. (1987) Sequences coding for part of oncogene-induced transin are highly conserved in a related rat gene. Nucleic Acids Res., 15, 1139-1151.
13. Briggs, M.R., Kadonaga, J.T. Bell, S.P. and Tjian, R. (1986) Purification and biochemical characterization of the promoter-specific transcription factor, Sp1. Science, 234, 47-52.
14. Bussemakers, M.J., van-de-Ven, W.J., Debruyne, F.M. and Schalken, J.A. (1991) Identification of high mobility group protein I(Y) as potential progression marker for prostate cancer by differential hybridization analysis. Cancer Res., 51, 606-611.
15. Buttice, G., Quinones, S. and Kurkinen, M. (1991) The AP-1 site is required for basal expression but is not necessary for TPA-response of the human stromelysin gene. Nucleic Acids Res., 19, 3723-3731.
16. Chiappetta, G. et al. (1995) The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene, 10, 1307-1314.
17. Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
18. Cohen, D.R. and Curran, T. (1988) fra-1: a serum-inducible, cellular immediate-early gene that encodes a fos-related antigen. Mol. Cell. Biol., 8, 2063-2069.
19. Davis, R. (1994) MAPKs: new JNK expands the group. Trends Biochem. Sci., 19, 470-473.
20. De Cesare, D., Vallone, D., Caracciolo, A., Sassone-Corsi, P., Nerlov, C. and Verde, P. (1995) Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer. Oncogene, 11, 365-376.
21. de Wet, J.R., Wood, K.V., DeLuca, M., Helinski, D.R. and Subramani, S. (1987) Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol., 7, 725-737.
22. Fedele, M. et al. (1996) Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins. Cancer Res., 56, 1896-1901.
23. Fusco, A., Portella, G., Di Fiore, P.P., Berlingieri, M.T., Di Lauro, R., Schneider, A.B. and Vecchio, G. (1985) A mos oncogene-containing retrovirus, myeloproliferative sarcoma virus, transforms rat thyroid epithelial cells and irreversibly blocks their differentiation pattern. J. Virol., 56, 284-292.
24. Fusco, A., Berlingieri, M.T., Di Fiore, P.P., Portella, G., Grieco, M. and Vecchio, G. (1987) One- and two-step transformations of rat thyroid epithelial cells by retroviral oncogenes. Mol. Cell. Biol., 7, 3365-3370.
25. Gack, S., Vallon, R., Schaper, J., Ruther, U. and Angel, P. (1994) Phenotypic alterations in fos-transgenic mice correlate with changes in Fos/ Jun-dependent collagenase type I expression. Regulation of mouse metalloproteinases by carcinogens, tumor promoters, cAMP, and Fos oncoprotein. J. Biol. Chem., 269, 10363-10369.
26. Giancotti, V. et al. (1987) Elevated levels of a specific class of nuclear phosphoproteins in cells transformed with v-ras and v-mos oncogenes and by cotransfection with c-myc and polyoma middle T genes. EMBO J., 6, 1981-1987.
27. Giancotti, V., Bandiera, A., Ciani, L., Santoro, D., Crane-Robinson, C., Goodwin, G.H., Boiocchi, M., Dolcetti, R. and Casetta, B. (1993) High-mobility-group (HMG) proteins and histone H1 subtypes expression in normal and tumor tissues of mouse. Eur. J. Biochem., 213, 825-832.
28. Graham, F.L. and van der Eb, A.J. (1973) A new technique for the assay of the infectivity of human adenovirus 5 DNA. Virology, 52, 456-467.
29. Gruda, M.C., Kovary, K., Metz, R. and Bravo, R. (1994) Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity. Oncogene, 9, 2537-2547.
30. Gutman, A. and Wasylyk, B. (1991) Nuclear targets for transcription regulation by oncogenes. Trends Genet., 7, 49-54.
31. Hirai, S.I., Ryseck, R.P. Mechta, F., Bravo, R. and Yaniv, M. (1989) Characterization of junD: a new member of the jun proto-oncogene family. EMBO J., 8, 1433-1439.
32. Karin, M. (1995) The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem., 270, 16483-16486.
33. Lee, W., Mitchell, P. and Tjian, R. (1987) Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell, 49, 741-752.
34. Macpherson, I. and Montagnier, L. (1964) Agar suspension culture for the selective assay of cells transformed by polyoma virus. Virology, 23, 291-294.
35. Maher, J.F. and Nathans, D. (1996) Multivalent DNA-binding properties of the HMG-1 proteins. Proc. Natl Acad. Sci. USA, 93, 6716-6720.
36. Manfioletti, G., Giancotti, V., Bandiera, A., Buratti, E., Sautiere, P., Cary, P., Crane-Robinson, C. Coles, B. and Goodwin, G.H. (1991) cDNA cloning of the HMGI-C phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes. Nucleic Acids Res., 19, 6793-6797.
37. Matrisian, L.M. (1994) Matrix metalloproteinase gene expression. Ann. NY Acad. Sci., 732, 42-50.
38. Mechta, F., Lallemand, D., Pfarr, C.M. and Yaniv, M. (1997) Transformation by ras modifies AP1 composition and activity. Oncogene, 14, 837-847.
39. Miller, A.D., Curran, T. and Venna, I.M. (1984) c-fos protein can induce cellular transformation: a novel mechanism of activation of a cellular oncogene. Cell, 36, 51-60.
40. Okazaki, K. and Sagata, N. (1995) The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH 3T3 cells. EMBO J., 14, 5048-5059.
41. Papavassiliou, A.G., Treier, M. and Bohmann, D. (1995) Intramolecular signal transduction in c-Jun. EMBO J., 14, 2014-2019.
42. Pfarr, C.M., Mechta, F., Spyrou, G., Lallemand, D., Carillo, S. and Yaniv, M. (1994) Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras. Cell, 76, 747-760.
43. Ram, T.G., Reeves, R. and Hosick, H.L. (1993) Elevated high mobility group-I(Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells. Cancer Res., 53, 2655-2660.
44. Ransone, L.J. and Verma, I.M. (1990) Nuclear proto-oncogenes fos and jun. Annu. Rev. Cell Biol., 6, 539-557.
45. Ryder, K., Lau, L.F. and Nathans, D. (1988) A gene activated by growth factors is related to the oncogene v-jun. Proc. Natl Acad. Sci. USA, 85, 1487-1491.
46. Saez, E., Rutberg, S.E., Mueller, E., Oppenheim, H., Smoluk, J., Yuspa, S.H. and Spiegelman, B.M. (1995) c-fos is required for malignant progression of skin tumors. Cell, 82, 721-732.
47. Schoenmakers, E.F., Wanschura, S., Mols, R., Bullerdiek, J., Van den Berghe, H. and Van de Ven, W.J. (1995) Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nature Genet., 10, 436-444.
48. Schutte, J., Minna, J.D. and Birrer, M.J. (1989) Deregulated expression of human c-jun transforms primary rat embryo cells in cooperation with an activated c-Ha-ras gene and transforms rat-1a cells as a single gene. Proc. Natl Acad. Sci. USA. 86, 2257-2261.
49. Tamimi, Y., van-der-Poel, H.G., Denyn, M.M., Umbas, R., Karthaus, H.F., Debruyne, F.M. and Schalken, J.A. (1993) Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization. Cancer Res., 53, 5512-5516.
50. Thanos, D. and Maniatis, T. (1995) Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell, 83, 1091-1100.
51. Treier, M., Staszewski, L.M. and Bohmann, D. (1994) Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell, 78, 787-798.
52. Van Amsterdam, J.R., Wang, Y., Sullivan, R.C. and Zarbl, H. (1994) Elevated expression of the junB proto-oncogene is essential for v-fos induced transformation of Rat-1 cells. Oncogene, 9, 2969-2976.
53. Vandel, L., Montreau, N., Vial, E., Pfarr, C.M., Binetruy, B. and Castellazzi, M. (1996) Stepwise transformation of rat embryo fibroblasts: c-Jun, JunB, or JunD can cooperate with Ras for focus formation, but a c-Jun-containing heterodimer is required for immortalization. Mol. Cell. Biol., 16, 1881-1888.
54. Viglietto, G. et al. (1995) Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines. Oncogene, 11, 1569-79.
55. Wanschura, S., Kazmierczak, B., Pohnke, Y., Meyer-Bolte, K., Bartnitzke, S., Van-de-Ven, W.J. and Bullerdiek, J. (1996) Transcriptional activation of HMGI-C in three pulmonary hamartomas each with a der(14)t(12; 14) as the sole cytogenetic abnormality. Cancer Lett., 102, 17-21.
56. Wisdom, R., Yen, J., Rashid, D. and Verma, I.M. (1992) Transformation by FosB requires a trans-activation domain missing in FosB2 that can be substituted by heterologous activation domains. Genes Dev., 6, 667-675.
57. Zerial, M., Toschi, L., Ryseck, R.P., Schuermann, M., Muller, R. and Bravo, R. (1989) The product of a novel growth factor activated gene, fosB, interacts with JUN proteins enhancing their DNA binding activity. EMBO J., 8, 805-813.